Institutional investors purchased a net $3.1 million shares of NEO during the quarter ended June 2017, and now own 62.65% of the total float, a percentage that is typical for companies in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONGRESS ASSET MANAGEMENT CO. LL... Bought 117.8 Thousand shares of Neogenomics Inc
THE VANGUARD GROUP, INC. Bought 73.2 Thousand shares of Neogenomics Inc